Jump to content

Search by property

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

List of results

Niravath et al. (2019): Randomized controlled trial of high‐dose versus standard‐dose vitamin D3 for prevention of aromatase inhibitor‐induced arthralgia + (Stage I-III)
Crew et al. (2012): Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer + (Stage I-III (non-metastasised) hormone receptor–negative breast cancer Breast cancer stage at diagnosis: n(%) I: Poly E arm: 14(47) Placebo arm: 2(20) II Poly E arm: 9(30) Placebo arm: 6(60) III Poly E arm: 7(23) Placebo arm: 2(20))
Inglis et al. (2020): Effects of High-Dose Vitamin D Supplementation on Phase Angle and Physical Function in Patients with Prostate Cancer on ADT + (Stage I-IV)
Lua et al. (2015): Effects of inhaled ginger aromatherapy on chemotherapy-induced nausea and vomiting and health-related quality of life in women with breast cancer + (Stage I: n=5 Stage II: n=35 Stage III: n=15 Stage IV: n=5)
Johansson et al. (2021): Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Controlled Trial + (Stage II)
Arslan et al. (2015): Oral Intake of Ginger for Chemotherapy-Induced Nausea and Vomiting Among Women With Breast Cancer + (Stage II or III breast cancer, no significant differences between arms in cancer stage (p > 0.05))
Braga et al. (2015): Effect of Zinc Supplementation on Serological Response to Vaccination Against Streptococcus Pneumoniae in Patients Undergoing Chemotherapy for Colorectal Cancer + (Stage II, III, or IV)
Lin et al. (2010): Discrepancy of the effects of zinc supplementation on the prevention of radiotherapy-induced mucositis between patients with nasopharyngeal carcinoma and those with oral cancers: subgroup analysis of a double-blind, randomized study + (Stage II-IV and recurrent cancer)
Mantovani et al. (2010): Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia + (Stage III and IV)
Howells et al. (2011): Phase I randomised double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases - safety, pharmacokinetics and pharmacodynamics + (Stage IV colorectal cancer and hepatic metastases)
Khan et al. (2017): Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial + (Stage I–III hormone receptor positive breast cancer)
Dale et al. (2001): Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects + (Stage of disease per arm (n): Enzyme arm: Ib = 2, IIb = 16, IIIb = 42 Control arm: Ib = 0, IIb = 19, IIIb = 41 Performance status (WHO) per arm (n): Enzyme arm: 1 = 54, 2 = 6 Control arm: 1 = 51, 2 =9)
Urashima et al. (2019): Effect of Vitamin D Supplementation on Relapse-Free Survival Among Patients With Digestive Tract Cancers The AMATERASU Randomized Clinical Trial + (Stages I to III)
Lin et al. (2006): Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: a double-blind, randomized study + (Stages I-IV and primary and recurrent tumors)
Lin et al. (2008): Effects of zinc supplementation on clinical outcomes in patients receiving radiotherapy for head and neck cancers: a double-blinded randomized study + (Stages I-IV and primary and recurrent tumors)
Upadhyaya et al. (2017): Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differential thyroid cancer: A randomized-controlled trial + (Stages T1-3, N0-1, M0)
Kasseroller et al. (2003): Efficacy and tolerability of proteolytic enzymes as an anti-inflammatory agent in lymphoedema after axillary dissection due to mammary cancer + (State I-II)
Delanian et al. (2003): Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis + (Survivors)
Heggie et al. (2002): A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue + (T-Stage per arm: Aloe vera arm: 1 = 67; 2 = 38; 3 = 2; unknown = 0 Placebo arm: 1 = 67; 2 = 29; 3 = 1; unknown = 4)

Rao et al. (2014): The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study + (T1-TX, N0-NX, M0-MX)
Newling et al. (1995): Tryptophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer. Results of a prospective, randomised phase III study performed by the EORTC GU Group + (Ta/T1, N0/NX, M0)
Walsh et al. (2010): Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma + (The range of disease stages, based on pathologic evaluation, did not differ among patients enrolled in the two arms)
Goossens et al. (2016): Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial + (Transurethral resected urinary bladder carcinoma (non-invasive urinary bladder carcinoma, Ta, T1, Tis))
Marucci et al. (2017): Double-blind randomized phase III study comparing a mixture of natural agents versus placebo in the prevention of acute mucositis during chemoradiotherapy for head and neck cancer + (Tumor site: Oropharynx = 41; Nasopharynx = 26; Larynx = 13; Hypopharynx = 11; Oral cavity = 9; Unknown = 4 T-classification: T0=4; T1=17; T2=35; T3=27; T4=21)
Olsen et al. (2001): The effect of aloe vera gel/mild soap versus mild soap alone in preventing skin reactions in patients undergoing radiation therapy + (Tumor site: Head/neck: Aloe arm = 39%; Control arm = 43% Chest: Aloe arm = 58%; Control arm = 52% Abdomen/pelvis: Aloe arm = 0%; Control arm = 3% Extremities: Aloe arm = 3%; Control arm = 2%)
Sahebjamee et al. (2015): Comparative Efficacy of Aloe vera and Benzydamine Mouthwashes on Radiation-induced Oral Mucositis: A Triple-blind, Randomised, Controlled Clinical Trial + (Tumor stage per arm: Aloe arm: 1 = 0; 2 = 0; 3 = 9 (69.2%); 4 = 4 (30.8%) Placebo arm: 1 = 0; 2 = 0; 3 = 7 (53.8%); 4 = 6 (46.2%))
Puataweepong et. al (2009): The efficacy of oral Aloe vera juice for radiation induced mucositis in head and neck cancer patients: a double-blind placebo-controlled study + (Tumor staging Aloe arm: T1 = 3 (10%); T2 = 8 (28%); T3 = 6 (21%); T4 = 12 (41%) Placebo arm: T1 = 5 (16%); T2 = 8 (26%); T3 = 6 (19%); T4 = 11 (36%); Unknown = 1 (3%))
Dörr et al. (2007): Efficacy of Wobe-Mugos E for Reduction of Oral Mucositis after Radiotherapy + (Tx-T4 (50% T2), N0-N3 (55.6% N0), Mx-M1 (83.3% M0))
Mansouri et al. (2016): The Effect of Aloe Vera Solution on Chemotherapy-Induced Stomatitis in Clients with Lymphoma and Leukemia: A Randomized Controlled Clinical Trial + (Type of disease: Acute Myeloid Leukemia (AML): Control arm = 17 (26.6%); Aloe arm =10 (15.6%) Acute Lymphocytic Leukemia (ALL): Cobtrol arm = 15 (23.4%); Aloe arm = 22 (34.4%))
Sangthawan et al. (2015): Effects of zinc sulfate supplementation on cell-mediated immune response in head and neck cancer patients treated with radiation therapy + (n=28 stage I-II, n=38 stage III-IV, n=6 unknown)
Ribeiro et al. (2017): Effects of zinc supplementation on fatigue and quality of life in patients with colorectal cancer + (n=5 stage II, n=14 stage III, n=5 stage IV)
Shapiro et al. (2016): Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS) + (n=53 (46.9%) stage I, n=45 (39.8%) stage II, n=15 (13.3%) stage IIIA)
Sangthawan et al. (2013): A randomized double-blind, placebo-controlled trial of zinc sulfate supplementation for alleviation of radiation-induced oral mucositis and pharyngitis in head and neck cancer patients + (n=55 stage I-II, n=139 stage III-IV, n=8 unknown)
Watanabe et al. (2010): Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer + (n=6 stage II, n=2 stage III, n=21 stage IV, n=2 NA)
Liu et al. (2010): Influence of vitamin C on salivary absorbed dose of 131I in thyroid cancer patients: a prospective, randomized, single-blind, controlled trial + (pT1–T3, N0–N1, M0)
Lin et al. (2009): Effects of zinc supplementation on the survival of patients who received concomitant chemotherapy and radiotherapy for advanced nasopharyngeal carcinoma: follow-up of a double-blind randomized study with subgroup analysis + (stages III (n=5) and IV (n=29))

Retrieved from "https://camih.med.uni-jena.de/wiki/Special:SearchByProperty/:Cancer-20stage-20specification/T1-2D2,-20M0"